Sarepta Therapeutics logo
Sarepta Therapeutics SRPT
$ 98.62 -1.16%

Annual report 2024
added 02-28-2025

report update icon

Sarepta Therapeutics Financial Ratios 2011-2025 | SRPT

Annual Financial Ratios Sarepta Therapeutics

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

43.0 -23.8 -15.1 -14.9 -12.2 -12.1 -23.8 -75.1 -5.3 -2.3 -3.5 -7.6 -5.3 -50.3

P/S

5.3 10.3 11.4 8.9 12.6 22.8 28.6 24.6 260.2 401.0 49.2 59.5 17.2 2.5

EPS

2.5 -5.8 -8.0 -5.2 -7.1 -9.7 -5.5 -0.9 -5.5 -5.2 -3.4 -3.3 -5.1 -0.0

EV (Enterprise Value)

11.4 B 14.8 B 12.4 B 6.33 B 7.51 B 8.84 B 8.85 B 3.73 B 1.38 B 506 M 454 M 634 M 534 M 100 M

EBITDA per Share

2.69 -2.42 -5.65 -5.19 -6.89 -7.08 -5.21 -2.37 -5.31 -5.08 -3.25 -2.63 -1.19 -1.6

EV/EBITDA

-14.9 -11.6 -16.3 -25.1 -26.1 -5.0 -2.1 -3.2 -6.6 -16.1 -2.3

PEG

-0.75 3.0 -0.55 -1.02 -0.6 0.16 0.04 -0.89 0.95 0.04 1.46 -0.21 0.0 -0.54

P/B

6.6 14.9 27.6 6.7 8.9 10.6 8.3 4.8 4.2 2.6 1.9 3.4 5.2 3.8

P/CF

-49.1 -25.5 -32.7 -14.0 63.2 -16.7 -19.0 -15.0 -5.6 -3.3 -3.1 -12.4 -20.8 -4.5

ROE %

15.40 -62.37 -182.75 -45.13 -72.74 -87.40 -35.06 -6.42 -79.38 -115.59 -54.83 -45.30 -98.07 -7.47

ROA %

5.94 -16.42 -22.49 -13.30 -18.57 -39.23 -22.04 -3.88 -63.02 -80.37 -46.03 -38.41 -59.17 -4.26

ROCE %

14.27 -31.17 -139.29 -49.54 -74.06 -33.52 -23.55 -11.51 -75.77 -104.11 -51.82 -35.32 -23.55 -106.40

Current Ratio

1.6 1.4 1.1 1.4 1.3 5.5 8.2 13.9 5.0 3.6 6.7 7.5 2.5 2.2

DSO

96.2 90.3 71.9 66.1 65.0 90.0 59.5 69.6 352.0 1158.5 90.4 90.6 46.1 28.2

DIO

- - - - - 1105.5 1339.1 4150.1 35975.0 - - - - -

DPO

- - - - - 439.2 361.1 420.3 83360.4 - - - - -

Operating Cycle

96.2 90.3 71.9 66.1 65.0 1195.5 1398.6 4219.7 36327.0 - - - - -

Cash Conversion Cycle

96.2 90.3 71.9 66.1 65.0 756.3 1037.4 3799.4 -47033.4 - - - - -

All numbers in USD currency

Quarterly Financial Ratios Sarepta Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.35 0.07 0.38 - -0.46 -0.27 -5.86 - -2.94 -2.65 -1.2 - -0.6 -1.02 -2.1 -2.4 -2.5 -1.93 -0.23 -3.16 -1.7 -3.74 -1.07 -2.05 -1.15 -1.67 -0.55 -0.37 -0.78 -1.15 1.53 -1.62 -1.18 -1.35 -1.31 -1.44 -1.25 -1.01 -1.49 -1.08 -0.71 -0.85 -0.75 -0.23 -1.24 -0.6 -1.32 -2.36 -2.17 0.36 -0.78 -0.06 -0.18 0.06 0.02

EBITDA per Share

0.24 - 0.46 - -0.23 -1.5 -1.44 - -1.5 -2.41 -0.87 - -82.5 -2.1 -1.8 K -2.16 K -1.5 K -1.61 -1.46 -3.09 K -1.43 -3.57 -1 -2.03 K -0.93 -1.5 -0.44 -0.36 -0.65 -1.09 -0.69 -1.62 -1.09 -1.28 -1.28 -1.44 -1.15 -0.96 -1.47 -1.08 -0.76 -0.72 -0.65 -0.87 -0.71 -0.51 -0.47 -0.39 -0.25 -0.21 -0.29 -0.4 -0.46 -0.43 -0.28

ROE %

1.75 -6.35 -10.18 -81.09 -140.91 -195.38 -224.01 -103.94 -114.20 -64.63 -49.54 -58.27 -83.12 -98.66 -101.68 -72.74 -76.70 -66.34 -80.33 -87.40 -72.24 -64.20 -41.00 -35.06 -24.45 -23.10 -20.50 -6.42 -29.65 -40.46 -50.97 -79.38 -87.09 -97.52 -101.01 -115.59 -99.55 -84.06 -75.75 -54.83 -40.46 -45.67 -39.69 -45.30 -91.92 -114.98 -100.78 -98.07 -52.43 -25.32 -27.70 -7.47 -12.96 4.12 5.91

ROA %

0.93 -1.32 -2.28 -18.97 -27.14 -33.99 -36.66 -15.04 -16.85 -7.05 -10.00 -10.81 -17.15 -21.93 -24.03 -18.57 -25.15 -25.50 -35.61 -39.23 -34.88 -32.60 -24.09 -22.04 -15.29 -14.29 -12.46 -3.88 -22.90 -32.63 -42.50 -63.02 -65.79 -71.38 -71.98 -80.37 -71.80 -62.73 -58.93 -46.03 -34.00 -38.50 -33.56 -38.41 -65.66 -75.42 -64.96 -59.17 -31.48 -14.70 -16.27 -4.26 -7.39 2.35 3.37

ROCE %

- - - - -30.49 -60.98 -90.04 -69.69 -77.03 -53.88 -59.36 -70.24 -92.66 -103.31 -86.93 -74.06 -79.79 -76.90 -92.39 -86.23 -71.60 -63.28 -39.65 -33.29 -22.72 -21.75 -19.75 -21.75 -45.07 -56.04 -66.46 -79.22 -86.83 -97.23 -100.91 -115.68 -99.87 -86.28 -76.38 -54.02 -49.25 -45.55 -40.22 -36.29 -31.33 -26.99 -24.56 -23.87 -43.65 -73.32 -100.48 -112.24 -35.21 -31.63 -17.28

Current Ratio

1.5 1.5 1.4 1.4 1.3 1.3 1.3 1.1 1.2 - 1.4 1.4 1.2 1.2 1.2 1.3 1.3 1.3 1.3 1.8 1.8 1.8 1.8 2.7 2.7 2.7 2.7 2.5 2.5 2.5 2.5 4.8 4.8 4.8 4.8 3.3 3.3 3.3 3.3 6.2 6.2 6.2 6.2 6.6 6.6 6.6 6.6 2.5 2.5 2.5 2.5 - - - -

DSO

77.6 92.9 86.0 - 76.4 80.5 78.9 - 39.9 34.8 71.7 - 66.8 68.3 68.2 63.7 64.2 67.3 77.2 82.8 83.7 87.6 73.4 53.0 57.0 60.9 55.5 47.0 58.5 76.8 96.9 88.0 - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

77.6 92.9 86.0 - 76.4 80.5 78.9 - 39.9 34.8 71.7 - 66.8 68.3 68.2 63.7 64.2 67.3 77.2 82.8 83.7 87.6 73.4 53.0 57.0 60.9 55.5 47.0 58.5 76.8 96.9 88.0 - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

77.6 92.9 86.0 - 76.4 80.5 78.9 - 39.9 34.8 71.7 - 66.8 68.3 68.2 63.7 64.2 67.3 77.2 82.8 83.7 87.6 73.4 53.0 57.0 60.9 55.5 47.0 58.5 76.8 96.9 88.0 - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency